NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT04203641 2025-05-06L-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerHelix BioPharma CorporationPhase 1/2 Terminated28 enrolled